3/A

OWNERSHIP DOCUMENT

Company: Outlook Therapeutics, Inc.
Filed: September 25, 2017
Period of Report: September 7, 2017
Accession Number: 0000947871-17-000753

View Document ↗ View on SEC.gov ↗